Meningococcal polysaccharide vaccine failure in a patient with C7 deficiency and a decreased anti-capsular antibody response

References

• Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984; 63:243 - 73; PMID: 6433145
   PubMed Web of Science ®Google Scholar
• D’Amelio R, Agostoni A, Biselli R, Brai M, Caruso G, Cicardi M, et al. Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy. Scand J Immunol 1992; 35:589 - 95; http://dx.doi.org/10.1111/j.1365-3083.1992.tb03258.x; PMID: 1579859
   PubMed Web of Science ®Google Scholar
• Kallel-Sellami M, Abdelmalek R, Zerzeri Y, Laadhar L, Blouin J, Zitouni M, et al. Déficits héréditaires en protéines du complément au cours des méningites purulentes: étude de 61 patients adultes tunisiens et revue de la littérature. Arch Inst Pasteur Tunis 2006; 83:25 - 34; PMID: 19388594
   PubMedGoogle Scholar
• Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M, Meningococcal Research Group. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 1999; 353:1049 - 53; http://dx.doi.org/10.1016/S0140-6736(98)08350-0; PMID: 10199352
   PubMed Web of Science ®Google Scholar
• Bax WA, Cluysenaer OJ, Bartelink AK, Aerts PC, Ezekowitz RA, van Dijk H. Association of familial deficiency of mannose-binding lectin and meningococcal disease. Lancet 1999; 354:1094 - 5; http://dx.doi.org/10.1016/S0140-6736(99)02563-5; PMID: 10509505
   PubMed Web of Science ®Google Scholar
• Kuijper EJ, Fijen CA, Dankert J, Thiel S. Mannose-binding lectin and meningococcal disease. Lancet 1999; 354:338; http://dx.doi.org/10.1016/S0140-6736(05)75244-2; PMID: 10440336
   PubMed Web of Science ®Google Scholar
• Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37:1496 - 505; http://dx.doi.org/10.1086/379324; PMID: 14614673
   PubMed Web of Science ®Google Scholar
• Salit IE. Meningococcemia caused by serogroup W135. Association with hypogammaglobulinemia. Arch Intern Med 1981; 141:664 - 5; http://dx.doi.org/10.1001/archinte.1981.00340050110026; PMID: 6784688
   PubMed Web of Science ®Google Scholar
• Densen P. Complement deficiencies and infection. In: Volanakis JE, Frank MM, eds. The Human Complement System in Health and Disease. M Dekker, 1998: 409-421.
   Google Scholar
• Bishof NA, Welch TR, Beischel LS. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J Infect Dis 1990; 162:248 - 50; http://dx.doi.org/10.1093/infdis/162.1.248; PMID: 2355198
   PubMed Web of Science ®Google Scholar
• Densen P, Weiler JM, Griffiss JM, Hoffmann LG. Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination. N Engl J Med 1987; 316:922 - 6; http://dx.doi.org/10.1056/NEJM198704093161506; PMID: 3102964
   PubMed Web of Science ®Google Scholar
• Sprong T, Roos D, Weemaes C, Neeleman C, Geesing CL, Mollnes TE, et al. Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. Blood 2006; 107:4865 - 70; http://dx.doi.org/10.1182/blood-2005-07-2820; PMID: 16527897
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Snowden N, Dunbar EM, Haeney MR. Recurrent meningococcal septicaemia and properdin deficiency. J Infect 1995; 31:67 - 8; http://dx.doi.org/10.1016/S0163-4453(95)91550-8; PMID: 8522838
   PubMed Web of Science ®Google Scholar
• S Reis E, Falcão DA, Isaac L. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 2006; 63:155 - 68; http://dx.doi.org/10.1111/j.1365-3083.2006.01729.x; PMID: 16499568
   PubMed Web of Science ®Google Scholar
• Nielsen HE, Christensen KC, Koch C, Thomsen BS, Heegaard NH, Tranum-Jensen J. Hereditary, complete deficiency of complement factor H associated with recurrent meningococcal disease. Scand J Immunol 1989; 30:711 - 8; http://dx.doi.org/10.1111/j.1365-3083.1989.tb02480.x; PMID: 2532396
   PubMed Web of Science ®Google Scholar
• Thompson RA, Lachmann PJ. A second case of human C3b inhibitor (KAF) deficiency. Clin Exp Immunol 1977; 27:23 - 9; PMID: 849647
   PubMed Web of Science ®Google Scholar
• Teisner B, Elling P, Svehag SE, Poulsen L, Lamm LU, Sjöholm A. C3 nephritic factor in a patient with recurrent Neisseria meningitidis infections. Acta Pathol Microbiol Immunol Scand C 1984; 92:341 - 9; PMID: 6570081
   PubMedGoogle Scholar
• Ducret F, Decoux M, Pointet P, Lambert C, Grosperrin E, Sédaillan A. Déficit héréditaire en C5 et méningite récidivante à Neisseria meningitidis. Rev Med Interne 1988; 9:534 - 7; http://dx.doi.org/10.1016/S0248-8663(88)80021-3; PMID: 3067301
   PubMed Web of Science ®Google Scholar
• Lim D, Gewurz A, Lint TF, Ghaze M, Sepheri B, Gewurz H. Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis. J Pediatr 1976; 89:42 - 7; http://dx.doi.org/10.1016/S0022-3476(76)80924-9; PMID: 819642
   PubMed Web of Science ®Google Scholar
• Lee TJ, Utsinger PD, Snyderman R, Yount WJ, Sparling PF. Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria. J Infect Dis 1978; 138:359 - 68; http://dx.doi.org/10.1093/infdis/138.3.359; PMID: 100562
   PubMed Web of Science ®Google Scholar
• Petersen BH, Lee TJ, Snyderman R, Brooks GF. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med 1979; 90:917 - 20; PMID: 109025
   PubMed Web of Science ®Google Scholar
• Zoppi M, Weiss M, Nydegger UE, Hess T, Späth PJ. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe. Arch Intern Med 1990; 150:2395 - 9; http://dx.doi.org/10.1001/archinte.1990.00390220127027; PMID: 2241452
   PubMed Web of Science ®Google Scholar
• Andreoni J, Käyhty H, Densen P. Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals. J Infect Dis 1993; 168:227 - 31; http://dx.doi.org/10.1093/infdis/168.1.227; PMID: 8515116
   PubMed Web of Science ®Google Scholar
• Wedege E, Høiby EA, Rosenqvist E, Bjune G. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun 1998; 66:3223 - 31; PMID: 9632589
   PubMed Web of Science ®Google Scholar
• Schmiel DH, Moran EE, Keiser PB, Brandt BL, Zollinger WD. Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B. Infect Immun 2011; 79:4146 - 56; http://dx.doi.org/10.1128/IAI.05125-11; PMID: 21768280
   PubMed Web of Science ®Google Scholar
• Fijen CA, Kuijper EJ, Hannema AJ, Sjöholm AG, van Putten JP. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 1989; 2:585 - 8; http://dx.doi.org/10.1016/S0140-6736(89)90712-5; PMID: 2570284
   PubMed Web of Science ®Google Scholar
• Fijen CA, Kuijper EJ, Tjia HG, Daha MR, Dankert J. Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis 1994; 18:780 - 4; http://dx.doi.org/10.1093/clinids/18.5.780; PMID: 8075270
   PubMed Web of Science ®Google Scholar
• Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969; 129:1307 - 26; http://dx.doi.org/10.1084/jem.129.6.1307; PMID: 4977280
   PubMed Web of Science ®Google Scholar
• Jodar L, Cartwright K, Feavers IM. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines. Biologicals 2000; 28:193 - 7; http://dx.doi.org/10.1006/biol.2000.0253; PMID: 10964447
   PubMedGoogle Scholar
• Schlesinger M, Greenberg R, Levy J, Kayhty H, Levy R. Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency. J Infect Dis 1994; 170:449 - 53; http://dx.doi.org/10.1093/infdis/170.2.449; PMID: 8035035
   PubMed Web of Science ®Google Scholar
• Biselli R, Casapollo I, D’Amelio R, Salvato S, Matricardi PM, Brai M. Antibody response to meningococcal polysaccharides A and C in patients with complement defects. Scand J Immunol 1993; 37:644 - 50; http://dx.doi.org/10.1111/j.1365-3083.1993.tb01677.x; PMID: 8316762
   PubMed Web of Science ®Google Scholar
• Platonov AE, Beloborodov VB, Pavlova LI, Vershinina IV, Käyhty H. Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 1995; 100:32 - 9; http://dx.doi.org/10.1111/j.1365-2249.1995.tb03600.x; PMID: 7697919
   PubMed Web of Science ®Google Scholar
• Platonov AE, Vershinina IV, Kuijper EJ, Borrow R, Käyhty H. Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine. Vaccine 2003; 21:4437 - 47; http://dx.doi.org/10.1016/S0264-410X(03)00440-7; PMID: 14505927
   PubMed Web of Science ®Google Scholar
• Drogari-Apiranthitou M, Fijen CA, Van De Beek D, Hensen EF, Dankert J, Kuijper EJ. Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients. Clin Exp Immunol 2000; 119:311 - 6; http://dx.doi.org/10.1046/j.1365-2249.2000.01130.x; PMID: 10632668
   PubMed Web of Science ®Google Scholar
• Herva E, Leinonen M, Käyhty H, Mäkelä PH, Vetoniemi-Korhonen SL. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response. J Infect 1983; 6:55 - 60; http://dx.doi.org/10.1016/S0163-4453(83)95636-0; PMID: 6411822
   PubMed Web of Science ®Google Scholar
• Zangwill KM, Stout RW, Carlone GM, Pais L, Harekeh H, Mitchell S, et al. Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis 1994; 169:847 - 52; http://dx.doi.org/10.1093/infdis/169.4.847; PMID: 8133100
   PubMed Web of Science ®Google Scholar
• Platonov AE, Beloborodov VB, Vershinina IV. Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R. Medicine (Baltimore) 1993; 72:374 - 92; http://dx.doi.org/10.1097/00005792-199311000-00002; PMID: 8231787
   PubMed Web of Science ®Google Scholar
• Fijen CA, Kuijper EJ, Drogari-Apiranthitou M, Van Leeuwen Y, Daha MR, Dankert J. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 1998; 114:362 - 9; http://dx.doi.org/10.1046/j.1365-2249.1998.00738.x; PMID: 9844044
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Updated recommendations for use of meningococcal conjugate vaccines---Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2011; 60:72 - 6; PMID: 21270745
   PubMedGoogle Scholar
• Bilukha OO, Rosenstein N, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54:RR-7 1 - 21; PMID: 15917737
   PubMedGoogle Scholar
• Committee on Infectious Diseases. Meningococcal conjugate vaccines policy update: booster dose recommendations. Pediatrics 2011; 128:1213 - 8; http://dx.doi.org/10.1542/peds.2011-2380
   PubMed Web of Science ®Google Scholar
• Plested JS, Welsch JA, Granoff DM. Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity. Clin Vaccine Immunol 2009; 16:785 - 91; http://dx.doi.org/10.1128/CVI.00007-09; PMID: 19339487
   PubMed Web of Science ®Google Scholar
• Rameix-Welti MA, Régnier CH, Bienaimé F, Blouin J, Schifferli J, Fridman WH, et al. Hereditary complement C7 deficiency in nine families: subtotal C7 deficiency revisited. Eur J Immunol 2007; 37:1377 - 85; http://dx.doi.org/10.1002/eji.200636812; PMID: 17407100
   PubMed Web of Science ®Google Scholar
• Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4:359 - 95; PMID: 1889047
   PubMed Web of Science ®Google Scholar